Biosynthesis can be exploited for chemical synthesis in vitro or in cells like Escherichia coli by combining substrates with enzymes using recombinant methods. Medium- and branched-chain diols and ...

The board of Novo Banco, however, says the bank would be better off as a standalone lender. In June, state-owned Caixa Geral de Depositos (CGD) CEO Paulo Macedo said the country's largest bank was ...

The inflation rate in Germany is expected to be +2.3% in January 2025. It is measured as the change in the consumer price index (CPI) compared with the same month a year earlier. Based on the results ...

Lone Star plans to launch an IPO for up to 30% of Novo Banco, shifting from a full ... In June, the CEO of state-owned Caixa Geral de Depositos (CGD), Paulo Macedo, indicated that Portugal ...

Mechanistically, we found that PGAM regulates Treg differentiation by controlling flux through the de novo serine synthesis pathway. The PGAM substrate 3PG is also utilized for serine synthesis, and ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...

Presenting 24 images of cells, tissues and organisms, scientists at the Multiscale Imaging Centre of the University of Münster offer insights into their research. Additionally, a twelve-metre-high ...

"Although the α-D-ribofuranoside structure is frequently found in natural products, there have been fewer reports of the synthesis of α-D-ribofuranosides than of the β-anomers. Thus, the ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...